Parkman Healthcare Partners as of Sept. 30, 2025
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 91 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 5.0 | $48M | 80k | 600.37 | |
| Boston Scientific Corporation (BSX) | 4.4 | $42M | 434k | 97.63 | |
| Alnylam Pharmaceuticals (ALNY) | 4.2 | $40M | 88k | 456.00 | |
| Insulet Corporation (PODD) | 3.7 | $36M | 116k | 308.73 | |
| CVS Caremark Corporation (CVS) | 3.0 | $29M | 380k | 75.39 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 2.7 | $26M | 672k | 38.83 | |
| Miragen Therapeutics (VRDN) | 2.6 | $25M | 1.2M | 21.58 | |
| Zimmer Holdings (ZBH) | 2.6 | $25M | 251k | 98.50 | |
| Stryker Corporation (SYK) | 2.5 | $24M | 64k | 369.67 | |
| Qiagen Nv Com Shs (QGEN) | 2.3 | $22M | 500k | 44.68 | |
| McKesson Corporation (MCK) | 2.3 | $22M | 29k | 772.54 | |
| Danaher Corporation (DHR) | 2.3 | $22M | 111k | 198.26 | |
| Kalvista Pharmaceuticals (KALV) | 2.2 | $21M | 1.7M | 12.18 | |
| Uniqure Nv SHS (QURE) | 2.1 | $20M | 345k | 58.37 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $20M | 142k | 140.38 | |
| Biogen Idec (BIIB) | 1.9 | $18M | 130k | 140.08 | |
| Mineralys Therapeutics (MLYS) | 1.8 | $17M | 456k | 37.92 | |
| Upstream Bio (UPB) | 1.7 | $16M | 844k | 18.81 | |
| Tenet Healthcare Corp Com New (THC) | 1.6 | $15M | 74k | 203.04 | |
| Xeris Pharmaceuticals (XERS) | 1.5 | $15M | 1.8M | 8.14 | |
| Livanova SHS (LIVN) | 1.5 | $14M | 276k | 52.38 | |
| Mbx Biosciences (MBX) | 1.4 | $14M | 773k | 17.50 | |
| Amicus Therapeutics (FOLD) | 1.4 | $13M | 1.7M | 7.88 | |
| Doximity Cl A (DOCS) | 1.4 | $13M | 179k | 73.15 | |
| Syndax Pharmaceuticals (SNDX) | 1.4 | $13M | 847k | 15.38 | |
| Ptc Therapeutics I (PTCT) | 1.3 | $12M | 202k | 61.37 | |
| Arcellx Common Stock (ACLX) | 1.3 | $12M | 150k | 82.10 | |
| Edwards Lifesciences (EW) | 1.3 | $12M | 156k | 77.77 | |
| Cooper Cos (COO) | 1.3 | $12M | 177k | 68.56 | |
| Waystar Holding Corp (WAY) | 1.2 | $12M | 306k | 37.92 | |
| Dex (DXCM) | 1.2 | $12M | 172k | 67.29 | |
| Castle Biosciences (CSTL) | 1.1 | $11M | 476k | 22.77 | |
| Optimizerx Corp Com New (OPRX) | 1.1 | $10M | 510k | 20.50 | |
| Nuvalent Inc-a (NUVL) | 1.1 | $10M | 120k | 86.48 | |
| Alphatec Hldgs Com New (ATEC) | 1.1 | $10M | 697k | 14.54 | |
| CryoLife (AORT) | 1.0 | $9.4M | 221k | 42.34 | |
| United Therapeutics Corporation (UTHR) | 1.0 | $9.2M | 22k | 419.21 | |
| Axogen (AXGN) | 0.9 | $9.0M | 502k | 17.84 | |
| Edgewise Therapeutics (EWTX) | 0.9 | $8.9M | 550k | 16.22 | |
| Arcus Biosciences Incorporated (RCUS) | 0.9 | $8.9M | 653k | 13.60 | |
| Incyte Corporation (INCY) | 0.9 | $8.5M | 100k | 84.81 | |
| Travere Therapeutics (TVTX) | 0.8 | $8.1M | 340k | 23.90 | |
| Urogen Pharma (URGN) | 0.8 | $8.0M | 403k | 19.95 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $8.0M | 40k | 198.81 | |
| Amylyx Pharmaceuticals (AMLX) | 0.8 | $7.9M | 579k | 13.59 | |
| BioCryst Pharmaceuticals (BCRX) | 0.8 | $7.7M | 1.0M | 7.59 | |
| Veracyte (VCYT) | 0.8 | $7.7M | 223k | 34.33 | |
| Eli Lilly & Co. (LLY) | 0.8 | $7.6M | 10k | 763.00 | |
| Quidel Corp (QDEL) | 0.8 | $7.4M | 253k | 29.45 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $7.1M | 176k | 40.15 | |
| Terns Pharmaceuticals (TERN) | 0.7 | $7.0M | 935k | 7.51 | |
| Precigen (PGEN) | 0.7 | $6.9M | 2.1M | 3.29 | |
| Schrodinger (SDGR) | 0.7 | $6.8M | 340k | 20.06 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $6.8M | 126k | 54.16 | |
| Certara Ord (CERT) | 0.7 | $6.7M | 552k | 12.22 | |
| Assembly Biosciences Com New (ASMB) | 0.7 | $6.4M | 251k | 25.60 | |
| Outset Med Com New (OM) | 0.7 | $6.4M | 455k | 14.12 | |
| Inspiremd (NSPR) | 0.6 | $5.9M | 2.4M | 2.41 | |
| Stoke Therapeutics (STOK) | 0.6 | $5.9M | 250k | 23.50 | |
| Iqvia Holdings (IQV) | 0.6 | $5.7M | 30k | 189.94 | |
| Treace Med Concepts (TMCI) | 0.6 | $5.7M | 848k | 6.71 | |
| Si-bone (SIBN) | 0.6 | $5.6M | 379k | 14.72 | |
| Maze Therapeatics (MAZE) | 0.5 | $5.2M | 200k | 25.93 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.5 | $4.9M | 45k | 107.74 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.5 | $4.7M | 55k | 84.90 | |
| Apogee Therapeutics (APGE) | 0.4 | $4.2M | 106k | 39.73 | |
| Immunome (IMNM) | 0.4 | $4.1M | 351k | 11.71 | |
| Protagonist Therapeutics (PTGX) | 0.4 | $4.1M | 62k | 66.43 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $4.0M | 100k | 40.14 | |
| CVRX (CVRX) | 0.4 | $4.0M | 491k | 8.07 | |
| Mannkind Corp Com New (MNKD) | 0.4 | $3.5M | 656k | 5.37 | |
| Rxsight (RXST) | 0.4 | $3.4M | 381k | 8.99 | |
| Spyre Therapeutics Com New (SYRE) | 0.4 | $3.4M | 201k | 16.76 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.3 | $3.1M | 74k | 41.65 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.3 | $3.1M | 913k | 3.34 | |
| Vera Therapeutics Cl A (VERA) | 0.3 | $2.8M | 97k | 29.06 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.3 | $2.7M | 271k | 9.93 | |
| Tvardi Therapeutics (TVRD) | 0.3 | $2.5M | 65k | 38.97 | |
| Solid Biosciences Com New (SLDB) | 0.3 | $2.4M | 396k | 6.17 | |
| Day One Biopharmaceuticals I (DAWN) | 0.2 | $2.1M | 302k | 7.05 | |
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $2.1M | 69k | 30.08 | |
| 4d Molecular Therapeutics In (FDMT) | 0.2 | $1.7M | 200k | 8.69 | |
| Quanterix Ord (QTRX) | 0.1 | $1.4M | 252k | 5.43 | |
| Annexon (ANNX) | 0.1 | $1.2M | 406k | 3.05 | |
| Butterfly Network Com Cl A (BFLY) | 0.1 | $1.2M | 602k | 1.93 | |
| 908 Devices (MASS) | 0.1 | $879k | 100k | 8.76 | |
| Pulmonx Corp (LUNG) | 0.1 | $811k | 501k | 1.62 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $573k | 100k | 5.73 | |
| Entera Bio SHS (ENTX) | 0.1 | $539k | 281k | 1.92 | |
| Edap Tms S A Sponsored Adr (EDAP) | 0.0 | $355k | 155k | 2.29 | |
| Ovid Therapeutics (OVID) | 0.0 | $264k | 203k | 1.30 |
